Mr. Steen: To ask the Secretary of State for Health what is his policy towards the provision of recombinant factor VIII for thetreatment of haemophilia sufferers. [18249]Mr. Boateng: We take the same sound and fair approach to all treatments, namely that they should be clinically effective and basedon sound evidence.Concerns have been raised about access to this particular treatment. We are actively addressing them.